Prevention of HPV re-infection by HPV vaccination after conization in patients with CIN 3
Phase of Trial: Phase IV
Latest Information Update: 13 May 2016
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Therapeutic Use
- 10 May 2012 Planned End Date changed to 1 Jul 2015.
- 10 May 2012 Status changed from not stated to recruiting.
- 10 May 2012 New trial record